BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22349466)

  • 1. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
    Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
    Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M
    Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
    Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
    S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication Errors Associated With Adverse Drug Reactions in Iran (2015-2017): A P-Method Approach.
    Karimian Z; Kheirandish M; Javidnikou N; Asghari G; Ahmadizar F; Dinarvand R
    Int J Health Policy Manag; 2018 Dec; 7(12):1090-1096. PubMed ID: 30709084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions in a Tertiary Care Emergency Medicine Ward - Prevalence, Preventability and Reporting.
    Rydberg DM; Holm L; Engqvist I; Fryckstedt J; Lindh JD; Stiller CO; Asker-Hagelberg C
    PLoS One; 2016; 11(9):e0162948. PubMed ID: 27622270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in a pulmonary teaching hospital: incidence, pattern, seriousness, and preventability.
    Baniasadi S; Fahimi F
    Curr Drug Saf; 2011 Sep; 6(4):230-6. PubMed ID: 22129318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a new instrument for detecting preventable adverse drug reactions.
    Benkirane R; Soulaymani-Bencheikh R; Khattabi A; Benabdallah G; Alj L; Sefiani H; Hedna K; Ouammi L; Olsson S; Pal SN
    Drug Saf; 2015 Apr; 38(4):383-93. PubMed ID: 25537235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventability of Adverse Drug Reactions Related to Antibiotics: An Assessment Based on Spontaneous Reporting System.
    Tran HN; Nguyen TNT; Tran NTK; Nguyen LT; Vu HD; Nguyen AH; Trinh NTH
    Ther Innov Regul Sci; 2023 Sep; 57(5):1104-1112. PubMed ID: 37389792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions induced by cotrimoxazole: Still a lot of preventable harm.
    Coppry M; Duret S; Berdaï D; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Rogues AM; Noize P
    Fundam Clin Pharmacol; 2022 Apr; 36(2):421-426. PubMed ID: 34699080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective pharmacovigilance study in the infectious diseases unit of a tertiary care hospital.
    Karaismailoglu B; Saltoglu N; Balkan II; Mete B; Tabak F; Ozturk R
    J Infect Dev Ctries; 2019 Jul; 13(7):649-655. PubMed ID: 32065823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients.
    Schmiedl S; Rottenkolber M; Szymanski J; Drewelow B; Siegmund W; Hippius M; Farker K; Guenther IR; Hasford J; Thuermann PA;
    Expert Opin Drug Saf; 2018 Feb; 17(2):125-137. PubMed ID: 29258401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.